PMID: 7008049Sep 1, 1980Paper

Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients

Postgraduate Medical Journal
A NichollsG R Catto


Septicaemia is a common and potentially lethal hazard of haemodialysis and renal transplantation; it is usually caused by Staphylococcus pyogenes. In 6 patients with S. pyogenes septicaemia, fatal endocarditis and spinal osteomyelitis have each occurred once, and 3 patients have had recurrent episodes of septicaemia. The management of septicaemia in these patients must include a search for metastatic infection, and prolonged therapy with 2 antistaphylococcal agents is necessary to ensure eradication of infection. Access site infection in dialysis patients must be treated vigorously, and recognized as potentially hazardous by patients. The risk of sepsis in dialysis and transplant patients cannot be excluded, but devastating consequences may be avoided by simple measures.


Jan 1, 1976·Nephron·H Dobbelstein
Oct 1, 1979·Archives of Internal Medicine·V T Andriole
Jan 1, 1979·The Medical Clinics of North America·G Gregoratos, J S Karliner
Jan 1, 1978·Annals of Internal Medicine·J F DobkinN H Steigbigel
Jan 1, 1975·Journal of Clinical Pathology·M H RebelW C Noble
Jul 15, 1976·The New England Journal of Medicine·L S WannH Feigenbaum
Oct 24, 1970·Lancet·D J Sherrard
May 1, 1973·Annals of Internal Medicine·A LeonardL Raij
Sep 1, 1973·The Annals of Thoracic Surgery·H C UrschelN F Galbraith
Dec 1, 1973·Kidney International·A LeonardF L Shapiro
Nov 1, 1973·Progress in Cardiovascular Diseases·L Weinstein, R H Rubin
Oct 17, 1974·The New England Journal of Medicine·L Weinstein, J J Schlesinger
Jan 1, 1973·Transactions - American Society for Artificial Internal Organs·A LeonardF L Shapiro
Jan 1, 1968·Medicine·J Z MontgomerieL B Guze
Aug 14, 1971·British Medical Journal·A J RalstonP Davis
Sep 9, 1972·British Medical Journal·R RaoH A Lee
Oct 1, 1972·Anesthesiology·D E Longnecker, P D Harris
Jan 1, 1971·The Journal of Infectious Diseases·E W HancockJ S Remington
Aug 1, 1971·The American Journal of the Medical Sciences·A J Morris, R T Bilinsky
Dec 20, 1969·British Medical Journal·C S McIntoshM Macleod
Apr 11, 1970·British Medical Journal·J R DathanG R Youngs
Jun 5, 1969·The New England Journal of Medicine·D M Kurtz
Apr 17, 1969·The New England Journal of Medicine·J S GoodmanM G Koenig
Nov 17, 1966·The New England Journal of Medicine·M J BresciaB J Hurwich
Jan 1, 1965·Annals of Internal Medicine·H S LAWRENCE


Nov 13, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·S DattaB Madden
Nov 27, 1982·British Medical Journal·P M Higgins
Feb 17, 2019·Journal of Neurosurgery. Spine·Karthik MadhavanMichael Y Wang
Mar 25, 2016·World Journal of Transplantation·Arnav Agarwal, G V Ramesh Prasad
Nov 18, 2003·Transplant Infectious Disease : an Official Journal of the Transplantation Society·P T D'CunhaK A Fisher

Related Concepts

Bacterial Endocarditis
Postoperative Complications
Staphylococcal Infections
Kidney Transplantation

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.